Sexually dimorphic effects of maternal nutrient reduction on expression of genes regulating cortisol metabolism in fetal baboon adipose and liver tissues

Diabetes

Volumn 62, Issue 4, 2013, Pages 1175-1185

  Guo, Chunming ^a   Li, Cun ^a   Myatt, Leslie ^a   Nathanielsz, Peter W ^a   Sun, Kang ^a,b  

^a University of Texas Health Science Center at San Antonio   (United States)

^b FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; GLUCOCORTICOID RECEPTOR; GLUCOSE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HYDROCORTISONE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ANIMAL EXPERIMENT; ARTICLE; BABOON; CONTROLLED STUDY; CORTICOSTEROID METABOLISM; FEMALE; FOOD INTAKE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HYDROCORTISONE BLOOD LEVEL; MALE; MATERNAL NUTRITION; MORPHOMETRICS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REGENERATION; SEX DIFFERENCE;

ADIPOSE TISSUE; ANIMAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; ANIMALS; BLOOD GLUCOSE; FEMALE; FETAL DEVELOPMENT; FOOD DEPRIVATION; GENE EXPRESSION REGULATION; HYDROCORTISONE; LIVER; MALE; MATERNAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; PAPIO; PREGNANCY; RANDOM ALLOCATION; SEX FACTORS;

EID: 84875445483     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db12-0561     Document Type: Article

References (50)

1. Harding JE. The nutritional basis of the fetal origins of adult disease. Int J Epidemiol 2001;30:15-23
2. Desai M, Crowther NJ, Lucas A, Hales CN. Organ-selective growth in the offspring of protein-restricted mothers. Br J Nutr 1996;76:591-603
3. Choi GY, Tosh DN, Garg A, Mansano R, Ross MG, Desai M. Gender-specific programmed hepatic lipid dysregulation in intrauterine growth-restricted offspring. Am J Obstet Gynecol 2007;196:477.e1-477.e7
4. Zheng S, Rollet M, Pan YX. Maternal protein restriction during pregnancy induces CCAAT/enhancer-binding protein (C/EBPb) expression through the regulation of histone modification at its promoter region in female offspring rat skeletal muscle. Epigenetics 2011;6:161-170
5. Choi J, Li C, McDonald TJ, Comuzzie A, Mattern V, Nathanielsz PW. Emergence of insulin resistance in juvenile baboon offspring of mothers exposed to moderate maternal nutrient reduction. Am J Physiol Regul Integr Comp Physiol 2011;301:R757-R762
6. McMillen IC, Robinson JS. Developmental origins of the metabolic syndrome: prediction, plasticity, and programming. Physiol Rev 2005;85:571-633
7. Hales CN, Barker DJ. The thrifty phenotype hypothesis. Br Med Bull 2001; 60:5-20
8. Dallman MF, Akana SF, Pecoraro NC, Warne JP, la Fleur SE, Foster MT. Glucocorticoids, the etiology of obesity and the metabolic syndrome. Curr Alzheimer Res 2007;4:199-204
9. Whorwood CB, Firth KM, Budge H, Symonds ME. Maternal undernutrition during early to midgestation programs tissue-specific alterations in the expression of the glucocorticoid receptor, 11beta-hydroxysteroid dehydrogenase isoforms, and type 1 angiotensin ii receptor in neonatal sheep. Endocrinology 2001;142:2854-2864
10. Bertram C, Trowern AR, Copin N, Jackson AA, Whorwood CB. The maternal diet during pregnancy programs altered expression of the glucocorticoid receptor and type 2 11beta-hydroxysteroid dehydrogenase: potential molecular mechanisms underlying the programming of hypertension in utero. Endocrinology 2001;142:2841-2853
11. Wake DJ, Rask E, Livingstone DE, Söderberg S, Olsson T, Walker BR. Local and systemic impact of transcriptional up-regulation of 11betahydroxysteroid dehydrogenase type 1 in adipose tissue in human obesity. J Clin Endocrinol Metab 2003;88:3983-3988
12. Rask E, Olsson T, Söderberg S, et al. Tissue-specific dysregulation of cortisol metabolism in human obesity. J Clin Endocrinol Metab 2001;86: 1418-1421
13. Strain GW, Zumoff B, Strain JJ, Levin J, Fukushima DK. Cortisol production in obesity. Metabolism 1980;29:980-985
14. Walker BR, Andrew R. Tissue production of cortisol by 11beta-hydroxysteroid dehydrogenase type 1 and metabolic disease. Ann N Y Acad Sci 2006;1083:165-184
15. Tomlinson JW, Walker EA, Bujalska IJ, et al. 11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr Rev 2004;25:831-866
16. Gaillard D, Wabitsch M, Pipy B, Négrel R. Control of terminal differentiation of adipose precursor cells by glucocorticoids. J Lipid Res 1991;32: 569-579
17. Chrousos GP. Is 11beta-hydroxysteroid dehydrogenase type 1 a good therapeutic target for blockade of glucocorticoid actions? Proc Natl Acad Sci U S A 2004;101:6329-6330
18. Kotelevtsev Y, Holmes MC, Burchell A, et al. 11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoidinducible responses and resist hyperglycemia on obesity or stress. Proc Natl Acad Sci U S A 1997;94:14924-14929
19. Morton NM, Holmes MC, Fiévet C, et al. Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11beta-hydroxysteroid dehydrogenase type 1 null mice. J Biol Chem 2001;276:41293-41300
20. Masuzaki H, Paterson J, Shinyama H, et al. A transgenic model of visceral obesity and the metabolic syndrome. Science 2001;294:2166-2170
21. Paterson JM, Morton NM, Fievet C, et al. Metabolic syndrome without obesity: Hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice. Proc Natl Acad Sci U S A 2004;101:7088-7093
22. McMillen IC, Warnes KE, Adams MB, Robinson JS, Owens JA, Coulter CL. Impact of restriction of placental and fetal growth on expression of 11betahydroxysteroid dehydrogenase type 1 and type 2 messenger ribonucleic acid in the liver, kidney, and adrenal of the sheep fetus. Endocrinology 2000;141:539-543
23. Nyirenda MJ, Carter R, Tang JI, et al. Prenatal programming of metabolic syndrome in the common marmoset is associated with increased expression of 11beta-hydroxysteroid dehydrogenase type 1. Diabetes 2009;58: 2873-2879
24. VandeBerg JL, Williams-Blangero S. Advantages and limitations of nonhuman primates as animal models in genetic research on complex diseases. J Med Primatol 1997;26:113-119
25. Williams LJ, Lyons V, MacLeod I, et al. C/EBP regulates hepatic transcription of 11beta-hydroxysteroid dehydrogenase type 1. A novel mechanism for cross-talk between the C/EBP and glucocorticoid signaling pathways. J Biol Chem 2000;275:30232-30239
26. Yang Z, Guo C, Zhu P, Li W, Myatt L, Sun K. Role of glucocorticoid receptor and CCAAT/enhancer-binding protein alpha in the feed-forward induction of 11beta-hydroxysteroid dehydrogenase type 1 expression by cortisol in human amnion fibroblasts. J Endocrinol 2007;195:241-253
27. Lavery GG, Walker EA, Draper N, et al. Hexose-6-phosphate dehydrogenase knock-out mice lack 11 beta-hydroxysteroid dehydrogenase type 1-mediated glucocorticoid generation. J Biol Chem 2006;281:6546-6551
28. Marzolla V, Armani A, Zennaro MC, et al. The role of the mineralocorticoid receptor in adipocyte biology and fat metabolism. Mol Cell Endocrinol 2012;350:281-288
29. Vidal-Puig AJ, Considine RV, Jimenez-Liñan M, et al. Peroxisome proliferatoractivated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids. J Clin Invest 1997; 99:2416-2422
30. Cassuto H, Kochan K, Chakravarty K, et al. Glucocorticoids regulate transcription of the gene for phosphoenolpyruvate carboxykinase in the liver via an extended glucocorticoid regulatory unit. J Biol Chem 2005;280: 33873-33884
31. Schlabritz-Loutsevitch NE, Howell K, Rice K, et al. Development of a system for individual feeding of baboons maintained in an outdoor group social environment. J Med Primatol 2004;33:117-126
32. Nijland MJ, Mitsuya K, Li C, et al. Epigenetic modification of fetal baboon hepatic phosphoenolpyruvate carboxykinase following exposure to moderately reduced nutrient availability. J Physiol 2010;588:1349-1359
33. Grieves JL, Dick EJ Jr, Schlabritz-Loutsevich NE, et al. Barbiturate euthanasia solution-induced tissue artifact in nonhuman primates. J Med Primatol 2008;37:154-161
34. Tanuma Y, Tamamoto M, Ito T, Yokochi C. The occurrence of brown adipose tissue in perirenal fat in Japanese. Arch Histol Jpn 1975;38:43-70
35. Barker DJ, Winter PD, Osmond C, Margetts B, Simmonds SJ. Weight in infancy and death from ischaemic heart disease. Lancet 1989;2:577-580
36. Ravelli AC, van Der Meulen JH, Osmond C, Barker DJ, Bleker OP. Obesity at the age of 50 y in men and women exposed to famine prenatally. Am J Clin Nutr 1999;70:811-816
37. Barnes SK, Ozanne SE. Pathways linking the early environment to longterm health and lifespan. Prog Biophys Mol Biol 2011;106:323-336
38. Brawley L, Itoh S, Torrens C, et al. Dietary protein restriction in pregnancy induces hypertension and vascular defects in rat male offspring. Pediatr Res 2003;54:83-90
39. Bagby SP. Maternal nutrition, low nephron number, and hypertension in later life: pathways of nutritional programming. J Nutr 2007;137:1066-1072
40. Shepherd PR, Crowther NJ, Desai M, Hales CN, Ozanne SE. Altered adipocyte properties in the offspring of protein malnourished rats. Br J Nutr 1997;78:121-129
41. Wamil M, Seckl Jr. Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 as a promising therapeutic target. Drug Discov Today 2007;12:504-520
42. Nammi S, Dembele K, Nyomba BL. Increased 11beta-hydroxysteroid dehydrogenase type-1 and hexose-6-phosphate dehydrogenase in liver and adipose tissue of rat offspring exposed to alcohol in utero. Am J Physiol Regul Integr Comp Physiol 2007;292:R1101-R1109
43. Yang Z, Zhu P, Guo C, Zhu X, Sun K. Expression of 11beta-hydroxysteroid dehydrogenase type 1 in human fetal lung and regulation of its expression by interleukin-1beta and cortisol. J Clin Endocrinol Metab 2009;94: 306-313
44. Ignatova ID, Kostadinova RM, Goldring CE, Nawrocki AR, Frey FJ, Frey BM. Tumor necrosis factor-alpha upregulates 11beta-hydroxysteroid dehydrogenase type 1 expression by CCAAT/enhancer binding proteinbeta in HepG2 cells. Am J Physiol Endocrinol Metab 2009;296:E367-E377
45. Tanaka T, Yoshida N, Kishimoto T, Akira S. Defective adipocyte differentiation in mice lacking the C/EBPbeta and/or C/EBPdelta gene. EMBO J 1997;16:7432-7443
46. Wang ND, Finegold MJ, Bradley A, et al. Impaired energy homeostasis in C/EBP alpha knockout mice. Science 1995;269:1108-1112
47. Zennaro MC, Souque A, Viengchareun S, Poisson E, Lombès M. A new human MR splice variant is a ligand-independent transactivator modulating corticosteroid action. Mol Endocrinol 2001;15:1586-1598
48. Turner JD, Pelascini LP, Macedo JA, Muller CP. Highly individual methylation patterns of alternative glucocorticoid receptor promoters suggest individualized epigenetic regulatory mechanisms. Nucleic Acids Res 2008; 36:7207-7218
49. Thomassin H, Flavin M, Espinás ML, Grange T. Glucocorticoid- induced DNA demethylation and gene memory during development. EMBO J 2001; 20:1974-1983
50. Wyrwoll CS, Mark PJ, Waddell BJ. Developmental programming of renal glucocorticoid sensitivity and the renin-angiotensin system. Hypertension 2007;50:579-584